Drugs moving into the clinic: 24
The latest in a series of periodic roundups of drugs that have moved from preclinical research into clinical testing via the announcement of a Phase I trial or an application for a trial to industry regulators.
Archives for August 12, 2007
Hikma makes inroads into Egyptian pharma market
UK Hikma Pharmaceuticals has acquired Egyptian pharmaceutical company Alkan Pharma in a deal worth $60.5m (€44.2m), and establishes the London-based company in the Egyptian market.
LifeCycle gets fenofibrate approval in US
The lowest formulated dose of cholesterol-busting fenofibrate has been approved for the US market using a new formulation platform.
Pfizer offers insight on R&D outsourcing in Japan
Pfizer, among others, recently offered an insight into R&D outsourcing in Japan, where this services market is still fairly immature, with growth potential in several key areas.
Big pharma's wish list
Some of the world's largest pharma firms have set out what therapeutic areas and specific mechanisms are becoming more important to them, and which will be left by the wayside.
Scottish firm targets South Korea for cancer patch
Scottish company ProStrakan has landed a South Korean partner for its novel transdermal patch for chemotherapy-induced nausea, the firm's first patch product with ambitions to steal a sizeable chunk of a €2bn market.
Invitrogen takes the stress out of stem cell 'passaging'
The launch of Invitrogen's Stempro EZPassage should substantially reduce the time and stress involved in dividing up cultures of human embryonic stem cell (hESC) colonies.
IMA investments paying off
Pharmaceutical packaging and processing machinery specialist IMA has announced its half year results, with its active expansion plans paying dividends and its pharma business going strong.